Epilepsy treatment

Medical Students
Medical StudentsMedical Students
Pharmacology of Antiepileptic DrugsPharmacology of Antiepileptic Drugs
Basic Mechanisms UnderlyingBasic Mechanisms Underlying
Seizures and EpilepsySeizures and Epilepsy
 Seizure: the clinical manifestation of an
abnormal and excessive excitation and
synchronization of a population of cortical
neurons
 Epilepsy: a disease characterized by
spontaneous recurrent seizures
 Epileptogenesis: sequence of events that
converts a normal neuronal network into an
epileptic network
Partial SeizuresPartial Seizures
 Simple
 Complex
 Secondary generalized
localized onset can be determined
Simple Partial SeizureSimple Partial Seizure
• Focal with minimal spread of abnormal
discharge
• normal consciousness and awareness are
maintained
Complex Partial SeizuresComplex Partial Seizures
 Local onset, then spreads
 Impaired consciousness
 Clinical manifestations vary with site of
origin and degree of spread
– Presence and nature of aura
– Automatisms
– Other motor activity
 Temporal lobe epilepsy
most common
Secondarily Generalized SeizuresSecondarily Generalized Seizures
 Begins focally, with or without focal neurological
symptoms
 Variable symmetry, intensity, and duration of tonic
(stiffening) and clonic (jerking) phases
 Typical duration up to 1-2 minutes
 Postictal confusion and somnolence
Generalized SeizuresGeneralized Seizures
In generalized seizures,
both hemispheres are
widely involved from
the outset.
Manifestations of the
seizure are
determined by the
cortical site at which
the seizure arises.
Present in 40% of all
epileptic Syndromes.
Generalized seizuresGeneralized seizures
• Absence seizures (Petit mal): sudden onset and
abrupt cessation; brief duration, consciousness is
altered; attack may be associated with mild clonic
jerking of the eyelids or extremities, postural tone
changes, autonomic phenomena and automatisms
(difficult diagnosis from partial); characteristic 2.5-3.5
Hz spike-and wave pattern
• Myoclonic seizures: myoclonic jerking is seen in a
wide variety of seizures but when this is the major
seizure type it is treated differently to some extent from
partial leading to generalized
Generalized Seizures (cont)Generalized Seizures (cont)
• Atonic seizures: sudden loss of postural tone;
most often in children but may be seen in adults
• Tonic-clonic seizures (grand mal): major
convulsions with rigidity (tonic) and jerking
(clonic), this slows over 60-120 sec followed by
stuporous state (post-ictal depression)
• Recruitment of neurons throughout the cortex
• Major convulsions, usually with two phases:
• 1) Tonic phase: muscles will suddenly tense up, causing the
person to fall to the ground if they are standing.
• 2) Clonic phase: muscles will start to contract
• and relax rapidly, causing convulsions
• Convulsions:
− motor manifestations
− may or may not be present during seizures
− excessive neuronal discharge
• Convulsions appear in Simple Partial and Complex Partial
Seizures if the focal neuronal discharge includes motor centers;
they occur in all Generalized Tonic-Clonic Seizures regardless of
the site of origin.
• Atonic and absence Seizures are non-convulsive
•
Generalized Tonic-Clonic SeizuresGeneralized Tonic-Clonic Seizures
Status EpilepticusStatus Epilepticus
• More than 30 minutes of continuous seizure
activity
• Two or more sequential seizures spanning
this period without full recovery between
seizures
• Medical emergency
Antiepileptic DrugAntiepileptic Drug
 A drug which decreases the frequency and/or
severity of seizures in people with epilepsy
 Treats the symptom of seizures, not the
underlying epileptic condition
 Goal—maximize quality of life by minimizing
seizures and adverse drug effects
 Currently no “anti-epileptogenic” drugs
available
Therapy Has Improved SignificantlyTherapy Has Improved Significantly
• “Give the sick person some blood from a
pregnant donkey to drink; or steep linen in it, dry
it, pour alcohol onto it and administer this”.
– Formey, Versuch einer medizinischen Topographie
von Berlin 1796, p. 193
Current PharmacotherapyCurrent Pharmacotherapy
• Just under 60% of all people with epilepsy can
become seizure free with drug therapy
• In another 20% the seizures can be drastically
reduced
• ~ 20% epileptic patients, seizures are refractory
to currently available AEDs
Choosing Antiepileptic DrugsChoosing Antiepileptic Drugs
 Seizure type
 Epilepsy syndrome
 Pharmacokinetic profile
 Interactions/other medical conditions
 Efficacy
 Expected adverse effects
 Cost
General Facts About AEDsGeneral Facts About AEDs
• Good oral absorption and bioavailability
• Most metabolized in liver but some excreted
unchanged in kidneys
• Classic AEDs generally have more severe CNS
sedation than newer drugs (except
ethosuximide)
• Because of overlapping mechanisms of action,
best drug can be chosen based on minimizing
side effects in addition to efficacy
Classification of AEDsClassification of AEDs
Classical
• Phenytoin
• Phenobarbital
• Primidone
• Carbamazepine
• Ethosuximide
• Valproate (valproic acid)
• Trimethadione (not currently
in use)
Newer
• Lamotrigine
• Felbamate
• Topiramate
• Gabapentin/Pregabalin
• Tiagabine
• Vigabatrin
• Oxycarbazepine
• Levetiracetam
• Fosphenytoin
MECHANISM OF ACTION OF ANTIEPILEPTIC DRUGS
Antiepileptics inhibit the neuronal discharge or its spread in one or
more of the following ways:
(1) Enhancing GABA synaptic transmission: barbiturates, benzo-
diazepines, gabapentin, levetiracetam, tiagabine, vigabatrin, topira-
mate, valproate; the result is increased permeability to chloride ion,
which reduces neuronal excitability. Valproate and topiramate block
GABA transaminase and tiagabine blocks reuptake of GABA.
(2) Reducing cell membrane permeability to voltage-dependent
sodium channels: carbamazepine, lamotrigine, oxcarbazepine,
phenytoin, topiramate, valproate.
(3) Reducing cell membrane permeability to calcium T-channels:
valproate, ethosuximide; the result is diminishing of the generation
of action potential.
(4) Inhibiting excitory neurotransmitter glutamate: lamotrigine.
Carbamazepine
Lamotrigine
Oxcarbazepine
Phenytoin
Topiramate
Valproate
Ethosuximide
Levetiracetam
Pregabalin
Valproate
Barbiturates
Benzodiazepines
Gabapentin
Levetiracetam
Tiagabine
Topiramate
Valproate
Vigabatrin
Na+Na+
Ca2+Ca2+
GABAGABA
Side effect issuesSide effect issues
• Sedation - especially with barbiturates
• Cosmetic – phenytoin (hirsutism gingival
hyperplasia-porphyria)
• Weight gain – valproic acid, gabapentin
• Weight loss - topiramate
• Reproductive function – valproic acid
• Cognitive - topiramate
• Behavioral – felbamate, leviteracetam
• Allergic - many
Stevens–Johnson syndrome
CellularCellular
Mechanisms ofMechanisms of
Seizure GenerationSeizure Generation
Targets for AEDsTargets for AEDs
• Increase inhibitory neurotransmitter system—
GABA
• Decrease excitatory neurotransmitter system—
glutamate
• Block voltage-gated inward positive currents—
Na+ or Ca++
• Increase outward positive current—K+
• Many AEDs pleiotropic—act via multiple
mechanisms
Epilepsy—GlutamateEpilepsy—Glutamate
 The brain’s major excitatory neurotransmitter
 Two groups of glutamate receptors
– Ionotropic—fast synaptic transmission
• NMDA, AMPA, kainate
• Gated Ca++
and Gated Na+ channels
– Metabotropic—slow synaptic transmission
• Regulation of second messengers (cAMP and
Inositol)
• Modulation of synaptic activity
 Modulation of glutamate receptors
– Glycine, polyamine sites, Zinc, redox site
Epilepsy—GlutamateEpilepsy—Glutamate
Glutamate Receptors as AED TargetsGlutamate Receptors as AED Targets
• NMDA receptor sites as targets
– Ketamine, phencyclidine, dizocilpine block channel
and have anticonvulsant properties but also
dissociative and/or hallucinogenic properties; open
channel blockers.
• AMPA receptor sites as targets
– Since it is the “workhorse” receptor can anticipate
major sedative effects
FelbamateFelbamate
• Antagonizes the glycine site on the NMDA
receptor and blocks Na+ channels*
• Very potent AED lacking sedative effect (unlike
nearly all other AEDs)
• Associated with rare but fatal aplastic anemia,
hence is restricted for use only in extreme
refractory epilepsy
TopiramateTopiramate
• Acts on AMPA receptors, blocking the glutamate binding
site, but also blocks kainate receptors and Na+
channels, and enhances GABA currents (highly
pleiotropic*)
• Used for partial seizures, as an adjunct for absence and
tonic-clonic seizures (add-on or alternative to phenytoin)
• Very long half-life (20h)
Epilepsy—GABAEpilepsy—GABA
 Major inhibitory neurotransmitter in the
CNS
 Two types of receptors
– GABAA—post-synaptic, specific
recognition sites, CI-
channel
– GABAB —presynaptic autoreceptors,
also postsynaptic, mediated by K+
currents
GABAGABAAA ReceptorReceptor
ClonazapamClonazapam
• -Benzodiazepine used for absence seizures
(and sometimes myoclonic): “fourth-line AED”
• -Most specific AED among benzodiazepines,
appearing to be selective for GABAA activation
in the reticular formation leading to inactivation
of T-type Ca2+ channels, hence its useful for
absence seizures
• -Sedating; May lose effectiveness due to
development of tolerance (≤6 months)
Lorazapam and DiazepamLorazapam and Diazepam
• Benzodiazepines used as first-line treatment for
status epilepticus (delivered IV – fast acting)
• Sedating
PhenobarbitalPhenobarbital
– Barbiturate used for partial seizures, especially in
neonates. Oldest of the currently used AEDs
– Very strong sedation; Cognitive impairment;
Behavioral changes
– Very long half-life (up to ~5days); #Induces P450
– Tolerance may arise; Risk of dependence
– Primidone, another barbiturate metabolized to
Phenobarbital, and Phenobarbital are now seldom
used in initial therapy, owing to side-effects
Tiagabine
– Interferes with GABA re-uptake
Vigabatrin (not currently available in US)
– elevates GABA levels by irreversibly inhibiting
its main catabolic enzyme, GABA-
transaminase
AEDs That Act Primarily on GABAAEDs That Act Primarily on GABA
Na+ Channels as AED TargetsNa+ Channels as AED Targets
• Neurons fire at high frequencies during seizures
• Action potential generation is dependent on Na+
channels
• Use-dependent or time-dependent Na+ channel
blockers reduce high frequency firing without
affecting physiological firing
A = activation gate
I = inactivation gate
McNamara JO. Goodman & Gilman’s. 9th ed. 1996:461-486.
Anticonvulsants:Anticonvulsants:
Mechanisms of ActionMechanisms of Action
Na+
Na+
Carbamazepine
Phenytoin
Lamotrigine
ValproateNa+
Na+
I I
Voltage-gated sodium channel
Open Inactivated
X
Phenytoin, Carbamazepine
– Block voltage-dependent sodium channels at high firing
frequencies—use dependent
Oxcarbazepine
– Blocks voltage-dependent sodium channels at high
firing frequencies
– Also effects K+ channels
Zonisamide
– Blocks voltage-dependent sodium channels and T-type
calcium channels
AEDs That Act Primarily on Na+AEDs That Act Primarily on Na+
ChannelsChannels
PhenytoinPhenytoin
• First-line for partial seizures; some use for tonic-
clonic seizures
• Highly bound to plasma proteins – displaced by
Valproate; #Induces P450 resulting in increase
in its own metabolism, but its metabolism is also
increased by alcohol, diazepam
• Sedating
• Fosphenytoin: Prodrug for Phenytoin, used for
IM injection
CarbamazapineCarbamazapine
• A tricyclic antidepressant used for partial
seizures; some use in tonic-clonic seizures
• #Induces P450 resulting in increase in its own
metabolism;
• Sedating; Agranulocytosis and Aplastic anemia
(elderly); Leukopenia (10% of patients);
Hyponatremia; Nausea and visual disturbances
OxcarbazapineOxcarbazapine
• Newer drug, closely related to Carbamazapine,
approved for monotherapy, or add-on therapy in
partial seizures
• May also augment K+ channels*
• Some #induction of P450 but much less than
that seen with Carbamazapine
• Sedating but otherwise less toxic than
Carbamazapine
ZonisamideZonisamide
• Used as add-on therapy for partial and
generalized seizures
• -Also blocks T-type Ca2+ channels*
• -Very long half-life (1-3days)
LamotrigineLamotrigine
• Add-on therapy, or monotherapy for refractory
partial seizures
• Also inhibits glutamate release and (perhaps)
Ca2+ channels (=pleiotropic*)
• Metabolism affected by Valproate,
Carbamazapine, Phenobarbital, Phenytoin
• Less sedating than other AEDs; (Severe
dermatitis in 1-2% of pediatric patients)
CaCa2+2+
Channels as TargetsChannels as Targets
• General Ca2+ channel blockers have not proven
to be effective AEDs.
• Absence seizures are caused by oscillations
between thalamus and cortex that are generated
in thalamus by T-type (transient) Ca2+ currents
EthosuximideEthosuximide
• Acts specifically on T-type channels in thalamus,
and is very effective against absence seizures.
• Long half-life (~40h)
• Causes GI disturbances; Less sedating than
other AEDs
GabapentinGabapentin and its second generationand its second generation
derivativederivative PregabalinPregabalin
• -Act specifically on calcium channel subunits
called α2δ1. It is unclear how this action leads to
their antiepileptic effects, but inhibition of
neurotransmitter release may be one
mechanism
• -Used in add-on therapy for partial seizures and
tonic-clonic seizures
• -Less sedating than classic AEDs
What about K+ channels?What about K+ channels?
• K+ channels have important inhibitory control over
neuronal firing in CNS—repolarizes membrane to
end action potentials
• K+ channel agonists would decrease
hyperexcitability in brain
• So far, the only AED with known actions on K+
channels is valproate
• Retiagabine is a novel AED in clinical trials that
acts on a specific type of voltage-dependent K+
channel (M-channel)
Valproate (Valproic Acid)Valproate (Valproic Acid)
• First-line for generalized seizures, also used for
partial seizures
• Also blocks Na+ channels and enhances
GABAergic transmission (highly pleiotropic*)
• Highly bound to plasma proteins; #Inhibits P450
• CNS depressant; GI disturbances; hair loss;
weight gain; teratogenic; (rare: hepatotoxic)
Regulation of Neurotransmitter releaseRegulation of Neurotransmitter release
• Several AED have actions that result in the
regulation of neurotransmitter release from the
presynaptic terminal, such as lamotrigine, in
addition to their noted action on ion channels or
receptors.
• Levetiracetam appears to have as its primary
action the regulation of neurotransmitter release
by binding to the synaptic vesicle protein SV2A:
LevetiracetamLevetiracetam
• -Add-on therapy for partial seizures
• -Short half-life (6-8h)
• -CNS depression
• Many AEDs act on multiple targets, increasing
their efficacy
• Felbamate, lamotrigine, topirmate, valproate
Pleiotropic AEDsPleiotropic AEDs
Drug InteractionsDrug Interactions
• Many AEDs are notable inducers of cytochrome
P450 enzymes and a few are inhibitors.
• Of the classic AEDs, phenytoin, carbamazipine,
phenobarbital, and primidone are all strong
inducers of cytochrome P450 enzymes. They
are autoinducers, in other words they increase
their own metabolism.
• Valproate inhibits cytochrome P450 enzymes.
Pharmacokinetic ConsiderationsPharmacokinetic Considerations
• Most AEDs undergo complete or nearly complete absorption when
given orally.
• Fosphenytoin (prodrug) may be administered intramuscularly if
intravenous access cannot be established in cases of frequent
repetitive seizures
• Diazepam (available as a rectal gel) has been shown to terminate
repetitive seizures and can be administered by family members at
home.
• Phenytoin, fosphenytoin, phenobarbital, diazepam, lorazepam and
valproate are available as IV preparations for emergency use.
• Most AEDs are metabolized in the liver (P450) by hydroxylation or
conjugation. These metabolites are then excreted by the kidney.
Gabapentin undergoes no metabolism and is excreted unchanged
by the kidney.
AED Treatment OptionsAED Treatment Options
MyoclonicTonic
Primary generalized seizuresPartial seizures
Simple
Complex
Secondary
Generalized
Ethosuximidephenytoin, carbamazepine, phenobarbital,
gabapentin, oxcarbazepine, pregabalin
valproic acid, lamotrigine, topiramate,
(levetiracetam, zonisamide)
Tonic-
Clonic
Atonic Absence
Check notes
Status EpilepticusStatus Epilepticus
• Treatment
– Diazepam, lorazapam IV (fast, short acting)
– Followed by phenytoin, fosphenytoin, or phenobarbital
(longer acting) when control is established
MAIN INDICATIONS OF ANTIEPILEPTIC DRUGS
Alternative methods
for treatment of epilepsy:
• Neurosurgery +
laser therapy
Questions?Questions?
1 sur 57

Recommandé

Antipsychotics - Pharmacology par
Antipsychotics - PharmacologyAntipsychotics - Pharmacology
Antipsychotics - PharmacologyAreej Abu Hanieh
24.3K vues24 diapositives
Anti-anxiety drugs par
Anti-anxiety drugsAnti-anxiety drugs
Anti-anxiety drugsDr Renju Ravi
36.2K vues27 diapositives
Recent advances in antiepileptics par
Recent advances in antiepilepticsRecent advances in antiepileptics
Recent advances in antiepilepticsDr. Vishal Pawar
1.1K vues46 diapositives
Parkinsonism treatment par
Parkinsonism treatmentParkinsonism treatment
Parkinsonism treatmentNaser Tadvi
12.1K vues32 diapositives
Treatment of epilepsy par
Treatment of epilepsyTreatment of epilepsy
Treatment of epilepsySrirama Anjaneyulu
5.1K vues41 diapositives
Antiseizure drugs par
Antiseizure drugsAntiseizure drugs
Antiseizure drugsMD Specialclass
7.5K vues48 diapositives

Contenu connexe

Tendances

Pharmacology - Parkinsonism par
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - ParkinsonismMBBS IMS MSU
71.5K vues31 diapositives
Pharmacotherapy of anxiety disorder par
Pharmacotherapy of anxiety disorderPharmacotherapy of anxiety disorder
Pharmacotherapy of anxiety disorderPreetKanwal14
351 vues36 diapositives
Levodopa par
LevodopaLevodopa
LevodopaDomina Petric
15.2K vues34 diapositives
Epilepsy & Antiepileptic Drugs par
Epilepsy & Antiepileptic DrugsEpilepsy & Antiepileptic Drugs
Epilepsy & Antiepileptic DrugsSyed Shayan
2.3K vues28 diapositives
Epilepsy par
EpilepsyEpilepsy
EpilepsyHimikaRathi
5.4K vues63 diapositives
Migrane ppt par
Migrane pptMigrane ppt
Migrane pptDeepak Sarangi
96.8K vues25 diapositives

Tendances(20)

Pharmacology - Parkinsonism par MBBS IMS MSU
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - Parkinsonism
MBBS IMS MSU71.5K vues
Pharmacotherapy of anxiety disorder par PreetKanwal14
Pharmacotherapy of anxiety disorderPharmacotherapy of anxiety disorder
Pharmacotherapy of anxiety disorder
PreetKanwal14351 vues
Epilepsy & Antiepileptic Drugs par Syed Shayan
Epilepsy & Antiepileptic DrugsEpilepsy & Antiepileptic Drugs
Epilepsy & Antiepileptic Drugs
Syed Shayan2.3K vues
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) par Sawsan Aboul-Fotouh
Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)Serotonin Norepinephrine Reuptake Inhibitors  (SNRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Selective serotonin reuptake inhibitors 2016 par Mohamed Sedky
Selective serotonin reuptake inhibitors 2016Selective serotonin reuptake inhibitors 2016
Selective serotonin reuptake inhibitors 2016
Mohamed Sedky39.4K vues
Class oral hypoglycemics par Raghu Prasada
Class oral hypoglycemicsClass oral hypoglycemics
Class oral hypoglycemics
Raghu Prasada39.4K vues

En vedette

Muscle physiology par
Muscle physiologyMuscle physiology
Muscle physiologyMedical Students
12.3K vues23 diapositives
Reflection par
Reflection Reflection
Reflection Medical Students
299 vues16 diapositives
Antiepileptic drugs par
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugsFred Ecaldre
944 vues44 diapositives
Basic requirements of microbial growth par
Basic requirements of microbial growthBasic requirements of microbial growth
Basic requirements of microbial growthMedical Students
9.9K vues11 diapositives
Antiepileptics par
Antiepileptics Antiepileptics
Antiepileptics Naser Tadvi
183.9K vues30 diapositives
Types of Seizure par
Types of SeizureTypes of Seizure
Types of SeizureAmarendra Singh
29.2K vues29 diapositives

Similaire à Epilepsy treatment

11 antiepileptic drugs par
11 antiepileptic drugs11 antiepileptic drugs
11 antiepileptic drugsJAMES MACHARIA
812 vues64 diapositives
Antiepileptic Drugs.pptx par
Antiepileptic Drugs.pptxAntiepileptic Drugs.pptx
Antiepileptic Drugs.pptxmonicaajmerajain
209 vues104 diapositives
Epilepsy.ppt par
Epilepsy.pptEpilepsy.ppt
Epilepsy.pptabomagaroma
10 vues35 diapositives
Epilepsy.ppt par
Epilepsy.pptEpilepsy.ppt
Epilepsy.pptabomagaroma
37 vues35 diapositives
Epilepsy par
Epilepsy Epilepsy
Epilepsy Dr. Vijay Prasad
2K vues75 diapositives
Anti epileptics agents pharmacology par
Anti epileptics agents pharmacologyAnti epileptics agents pharmacology
Anti epileptics agents pharmacologyKoppala RVS Chaitanya
589 vues38 diapositives

Similaire à Epilepsy treatment(20)

epilepsy-210211104538.pdf par Roop
epilepsy-210211104538.pdfepilepsy-210211104538.pdf
epilepsy-210211104538.pdf
Roop 24 vues
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D., par DrAshok Batham
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
DrAshok Batham643 vues
cns-antiepileptics-190304062504.pptx par shyam sunder
cns-antiepileptics-190304062504.pptxcns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptx
shyam sunder6 vues

Plus de Medical Students

amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease par
amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease  amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease
amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease Medical Students
1.8K vues19 diapositives
Malignant skin tumors par
Malignant skin tumorsMalignant skin tumors
Malignant skin tumorsMedical Students
3.1K vues17 diapositives
Lymphatic system anatomy par
Lymphatic system anatomyLymphatic system anatomy
Lymphatic system anatomyMedical Students
4.3K vues15 diapositives
topographic anatomy Abdomen par
topographic anatomy  Abdomentopographic anatomy  Abdomen
topographic anatomy AbdomenMedical Students
9.1K vues79 diapositives
Cardiovascular anatomy and vessels par
Cardiovascular anatomy and vesselsCardiovascular anatomy and vessels
Cardiovascular anatomy and vesselsMedical Students
283 vues30 diapositives
Brain 2015 par
Brain 2015Brain 2015
Brain 2015Medical Students
605 vues36 diapositives

Dernier

The relative risk of cancer from smoking and vaping nicotine par
The relative risk of cancer from smoking and vaping nicotine The relative risk of cancer from smoking and vaping nicotine
The relative risk of cancer from smoking and vaping nicotine yfzsc5g7nm
176 vues25 diapositives
PATIENTCOUNSELLING in.pptx par
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptxskShashi1
16 vues16 diapositives
CRANIAL NERVE EXAMINATION.pptx par
CRANIAL NERVE EXAMINATION.pptxCRANIAL NERVE EXAMINATION.pptx
CRANIAL NERVE EXAMINATION.pptxNerusu sai priyanka
160 vues30 diapositives
eTEP -RS Dr.TVR.pptx par
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptxVarunraju9
131 vues33 diapositives
CAPSULE par
 CAPSULE CAPSULE
CAPSULEGanapathi Vankudoth
62 vues24 diapositives
MEDICAL RESEARCH.pptx par
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptxrishi2789
48 vues38 diapositives

Dernier(20)

The relative risk of cancer from smoking and vaping nicotine par yfzsc5g7nm
The relative risk of cancer from smoking and vaping nicotine The relative risk of cancer from smoking and vaping nicotine
The relative risk of cancer from smoking and vaping nicotine
yfzsc5g7nm176 vues
PATIENTCOUNSELLING in.pptx par skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi116 vues
eTEP -RS Dr.TVR.pptx par Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9131 vues
MEDICAL RESEARCH.pptx par rishi2789
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
rishi278948 vues
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences par Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix LifesciencesTop PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Top PCD Pharma Franchise Companies in India | Saphnix Lifesciences
Structural Racism and Public Health: How to Talk to Policymakers and Communit... par katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley33627 vues
Referral-system_April-2023.pdf par manali9054
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905437 vues
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences par Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx par InkhaRina
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
InkhaRina32 vues

Epilepsy treatment

  • 1. Pharmacology of Antiepileptic DrugsPharmacology of Antiepileptic Drugs
  • 2. Basic Mechanisms UnderlyingBasic Mechanisms Underlying Seizures and EpilepsySeizures and Epilepsy  Seizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical neurons  Epilepsy: a disease characterized by spontaneous recurrent seizures  Epileptogenesis: sequence of events that converts a normal neuronal network into an epileptic network
  • 3. Partial SeizuresPartial Seizures  Simple  Complex  Secondary generalized localized onset can be determined
  • 4. Simple Partial SeizureSimple Partial Seizure • Focal with minimal spread of abnormal discharge • normal consciousness and awareness are maintained
  • 5. Complex Partial SeizuresComplex Partial Seizures  Local onset, then spreads  Impaired consciousness  Clinical manifestations vary with site of origin and degree of spread – Presence and nature of aura – Automatisms – Other motor activity  Temporal lobe epilepsy most common
  • 6. Secondarily Generalized SeizuresSecondarily Generalized Seizures  Begins focally, with or without focal neurological symptoms  Variable symmetry, intensity, and duration of tonic (stiffening) and clonic (jerking) phases  Typical duration up to 1-2 minutes  Postictal confusion and somnolence
  • 7. Generalized SeizuresGeneralized Seizures In generalized seizures, both hemispheres are widely involved from the outset. Manifestations of the seizure are determined by the cortical site at which the seizure arises. Present in 40% of all epileptic Syndromes.
  • 8. Generalized seizuresGeneralized seizures • Absence seizures (Petit mal): sudden onset and abrupt cessation; brief duration, consciousness is altered; attack may be associated with mild clonic jerking of the eyelids or extremities, postural tone changes, autonomic phenomena and automatisms (difficult diagnosis from partial); characteristic 2.5-3.5 Hz spike-and wave pattern • Myoclonic seizures: myoclonic jerking is seen in a wide variety of seizures but when this is the major seizure type it is treated differently to some extent from partial leading to generalized
  • 9. Generalized Seizures (cont)Generalized Seizures (cont) • Atonic seizures: sudden loss of postural tone; most often in children but may be seen in adults • Tonic-clonic seizures (grand mal): major convulsions with rigidity (tonic) and jerking (clonic), this slows over 60-120 sec followed by stuporous state (post-ictal depression)
  • 10. • Recruitment of neurons throughout the cortex • Major convulsions, usually with two phases: • 1) Tonic phase: muscles will suddenly tense up, causing the person to fall to the ground if they are standing. • 2) Clonic phase: muscles will start to contract • and relax rapidly, causing convulsions • Convulsions: − motor manifestations − may or may not be present during seizures − excessive neuronal discharge • Convulsions appear in Simple Partial and Complex Partial Seizures if the focal neuronal discharge includes motor centers; they occur in all Generalized Tonic-Clonic Seizures regardless of the site of origin. • Atonic and absence Seizures are non-convulsive • Generalized Tonic-Clonic SeizuresGeneralized Tonic-Clonic Seizures
  • 11. Status EpilepticusStatus Epilepticus • More than 30 minutes of continuous seizure activity • Two or more sequential seizures spanning this period without full recovery between seizures • Medical emergency
  • 12. Antiepileptic DrugAntiepileptic Drug  A drug which decreases the frequency and/or severity of seizures in people with epilepsy  Treats the symptom of seizures, not the underlying epileptic condition  Goal—maximize quality of life by minimizing seizures and adverse drug effects  Currently no “anti-epileptogenic” drugs available
  • 13. Therapy Has Improved SignificantlyTherapy Has Improved Significantly • “Give the sick person some blood from a pregnant donkey to drink; or steep linen in it, dry it, pour alcohol onto it and administer this”. – Formey, Versuch einer medizinischen Topographie von Berlin 1796, p. 193
  • 14. Current PharmacotherapyCurrent Pharmacotherapy • Just under 60% of all people with epilepsy can become seizure free with drug therapy • In another 20% the seizures can be drastically reduced • ~ 20% epileptic patients, seizures are refractory to currently available AEDs
  • 15. Choosing Antiepileptic DrugsChoosing Antiepileptic Drugs  Seizure type  Epilepsy syndrome  Pharmacokinetic profile  Interactions/other medical conditions  Efficacy  Expected adverse effects  Cost
  • 16. General Facts About AEDsGeneral Facts About AEDs • Good oral absorption and bioavailability • Most metabolized in liver but some excreted unchanged in kidneys • Classic AEDs generally have more severe CNS sedation than newer drugs (except ethosuximide) • Because of overlapping mechanisms of action, best drug can be chosen based on minimizing side effects in addition to efficacy
  • 17. Classification of AEDsClassification of AEDs Classical • Phenytoin • Phenobarbital • Primidone • Carbamazepine • Ethosuximide • Valproate (valproic acid) • Trimethadione (not currently in use) Newer • Lamotrigine • Felbamate • Topiramate • Gabapentin/Pregabalin • Tiagabine • Vigabatrin • Oxycarbazepine • Levetiracetam • Fosphenytoin
  • 18. MECHANISM OF ACTION OF ANTIEPILEPTIC DRUGS Antiepileptics inhibit the neuronal discharge or its spread in one or more of the following ways: (1) Enhancing GABA synaptic transmission: barbiturates, benzo- diazepines, gabapentin, levetiracetam, tiagabine, vigabatrin, topira- mate, valproate; the result is increased permeability to chloride ion, which reduces neuronal excitability. Valproate and topiramate block GABA transaminase and tiagabine blocks reuptake of GABA. (2) Reducing cell membrane permeability to voltage-dependent sodium channels: carbamazepine, lamotrigine, oxcarbazepine, phenytoin, topiramate, valproate. (3) Reducing cell membrane permeability to calcium T-channels: valproate, ethosuximide; the result is diminishing of the generation of action potential. (4) Inhibiting excitory neurotransmitter glutamate: lamotrigine.
  • 20. Side effect issuesSide effect issues • Sedation - especially with barbiturates • Cosmetic – phenytoin (hirsutism gingival hyperplasia-porphyria) • Weight gain – valproic acid, gabapentin • Weight loss - topiramate • Reproductive function – valproic acid • Cognitive - topiramate • Behavioral – felbamate, leviteracetam • Allergic - many
  • 23. Targets for AEDsTargets for AEDs • Increase inhibitory neurotransmitter system— GABA • Decrease excitatory neurotransmitter system— glutamate • Block voltage-gated inward positive currents— Na+ or Ca++ • Increase outward positive current—K+ • Many AEDs pleiotropic—act via multiple mechanisms
  • 24. Epilepsy—GlutamateEpilepsy—Glutamate  The brain’s major excitatory neurotransmitter  Two groups of glutamate receptors – Ionotropic—fast synaptic transmission • NMDA, AMPA, kainate • Gated Ca++ and Gated Na+ channels – Metabotropic—slow synaptic transmission • Regulation of second messengers (cAMP and Inositol) • Modulation of synaptic activity  Modulation of glutamate receptors – Glycine, polyamine sites, Zinc, redox site
  • 26. Glutamate Receptors as AED TargetsGlutamate Receptors as AED Targets • NMDA receptor sites as targets – Ketamine, phencyclidine, dizocilpine block channel and have anticonvulsant properties but also dissociative and/or hallucinogenic properties; open channel blockers. • AMPA receptor sites as targets – Since it is the “workhorse” receptor can anticipate major sedative effects
  • 27. FelbamateFelbamate • Antagonizes the glycine site on the NMDA receptor and blocks Na+ channels* • Very potent AED lacking sedative effect (unlike nearly all other AEDs) • Associated with rare but fatal aplastic anemia, hence is restricted for use only in extreme refractory epilepsy
  • 28. TopiramateTopiramate • Acts on AMPA receptors, blocking the glutamate binding site, but also blocks kainate receptors and Na+ channels, and enhances GABA currents (highly pleiotropic*) • Used for partial seizures, as an adjunct for absence and tonic-clonic seizures (add-on or alternative to phenytoin) • Very long half-life (20h)
  • 29. Epilepsy—GABAEpilepsy—GABA  Major inhibitory neurotransmitter in the CNS  Two types of receptors – GABAA—post-synaptic, specific recognition sites, CI- channel – GABAB —presynaptic autoreceptors, also postsynaptic, mediated by K+ currents
  • 31. ClonazapamClonazapam • -Benzodiazepine used for absence seizures (and sometimes myoclonic): “fourth-line AED” • -Most specific AED among benzodiazepines, appearing to be selective for GABAA activation in the reticular formation leading to inactivation of T-type Ca2+ channels, hence its useful for absence seizures • -Sedating; May lose effectiveness due to development of tolerance (≤6 months)
  • 32. Lorazapam and DiazepamLorazapam and Diazepam • Benzodiazepines used as first-line treatment for status epilepticus (delivered IV – fast acting) • Sedating
  • 33. PhenobarbitalPhenobarbital – Barbiturate used for partial seizures, especially in neonates. Oldest of the currently used AEDs – Very strong sedation; Cognitive impairment; Behavioral changes – Very long half-life (up to ~5days); #Induces P450 – Tolerance may arise; Risk of dependence – Primidone, another barbiturate metabolized to Phenobarbital, and Phenobarbital are now seldom used in initial therapy, owing to side-effects
  • 34. Tiagabine – Interferes with GABA re-uptake Vigabatrin (not currently available in US) – elevates GABA levels by irreversibly inhibiting its main catabolic enzyme, GABA- transaminase AEDs That Act Primarily on GABAAEDs That Act Primarily on GABA
  • 35. Na+ Channels as AED TargetsNa+ Channels as AED Targets • Neurons fire at high frequencies during seizures • Action potential generation is dependent on Na+ channels • Use-dependent or time-dependent Na+ channel blockers reduce high frequency firing without affecting physiological firing
  • 36. A = activation gate I = inactivation gate McNamara JO. Goodman & Gilman’s. 9th ed. 1996:461-486. Anticonvulsants:Anticonvulsants: Mechanisms of ActionMechanisms of Action Na+ Na+ Carbamazepine Phenytoin Lamotrigine ValproateNa+ Na+ I I Voltage-gated sodium channel Open Inactivated X
  • 37. Phenytoin, Carbamazepine – Block voltage-dependent sodium channels at high firing frequencies—use dependent Oxcarbazepine – Blocks voltage-dependent sodium channels at high firing frequencies – Also effects K+ channels Zonisamide – Blocks voltage-dependent sodium channels and T-type calcium channels AEDs That Act Primarily on Na+AEDs That Act Primarily on Na+ ChannelsChannels
  • 38. PhenytoinPhenytoin • First-line for partial seizures; some use for tonic- clonic seizures • Highly bound to plasma proteins – displaced by Valproate; #Induces P450 resulting in increase in its own metabolism, but its metabolism is also increased by alcohol, diazepam • Sedating • Fosphenytoin: Prodrug for Phenytoin, used for IM injection
  • 39. CarbamazapineCarbamazapine • A tricyclic antidepressant used for partial seizures; some use in tonic-clonic seizures • #Induces P450 resulting in increase in its own metabolism; • Sedating; Agranulocytosis and Aplastic anemia (elderly); Leukopenia (10% of patients); Hyponatremia; Nausea and visual disturbances
  • 40. OxcarbazapineOxcarbazapine • Newer drug, closely related to Carbamazapine, approved for monotherapy, or add-on therapy in partial seizures • May also augment K+ channels* • Some #induction of P450 but much less than that seen with Carbamazapine • Sedating but otherwise less toxic than Carbamazapine
  • 41. ZonisamideZonisamide • Used as add-on therapy for partial and generalized seizures • -Also blocks T-type Ca2+ channels* • -Very long half-life (1-3days)
  • 42. LamotrigineLamotrigine • Add-on therapy, or monotherapy for refractory partial seizures • Also inhibits glutamate release and (perhaps) Ca2+ channels (=pleiotropic*) • Metabolism affected by Valproate, Carbamazapine, Phenobarbital, Phenytoin • Less sedating than other AEDs; (Severe dermatitis in 1-2% of pediatric patients)
  • 43. CaCa2+2+ Channels as TargetsChannels as Targets • General Ca2+ channel blockers have not proven to be effective AEDs. • Absence seizures are caused by oscillations between thalamus and cortex that are generated in thalamus by T-type (transient) Ca2+ currents
  • 44. EthosuximideEthosuximide • Acts specifically on T-type channels in thalamus, and is very effective against absence seizures. • Long half-life (~40h) • Causes GI disturbances; Less sedating than other AEDs
  • 45. GabapentinGabapentin and its second generationand its second generation derivativederivative PregabalinPregabalin • -Act specifically on calcium channel subunits called α2δ1. It is unclear how this action leads to their antiepileptic effects, but inhibition of neurotransmitter release may be one mechanism • -Used in add-on therapy for partial seizures and tonic-clonic seizures • -Less sedating than classic AEDs
  • 46. What about K+ channels?What about K+ channels? • K+ channels have important inhibitory control over neuronal firing in CNS—repolarizes membrane to end action potentials • K+ channel agonists would decrease hyperexcitability in brain • So far, the only AED with known actions on K+ channels is valproate • Retiagabine is a novel AED in clinical trials that acts on a specific type of voltage-dependent K+ channel (M-channel)
  • 47. Valproate (Valproic Acid)Valproate (Valproic Acid) • First-line for generalized seizures, also used for partial seizures • Also blocks Na+ channels and enhances GABAergic transmission (highly pleiotropic*) • Highly bound to plasma proteins; #Inhibits P450 • CNS depressant; GI disturbances; hair loss; weight gain; teratogenic; (rare: hepatotoxic)
  • 48. Regulation of Neurotransmitter releaseRegulation of Neurotransmitter release • Several AED have actions that result in the regulation of neurotransmitter release from the presynaptic terminal, such as lamotrigine, in addition to their noted action on ion channels or receptors. • Levetiracetam appears to have as its primary action the regulation of neurotransmitter release by binding to the synaptic vesicle protein SV2A:
  • 49. LevetiracetamLevetiracetam • -Add-on therapy for partial seizures • -Short half-life (6-8h) • -CNS depression
  • 50. • Many AEDs act on multiple targets, increasing their efficacy • Felbamate, lamotrigine, topirmate, valproate Pleiotropic AEDsPleiotropic AEDs
  • 51. Drug InteractionsDrug Interactions • Many AEDs are notable inducers of cytochrome P450 enzymes and a few are inhibitors. • Of the classic AEDs, phenytoin, carbamazipine, phenobarbital, and primidone are all strong inducers of cytochrome P450 enzymes. They are autoinducers, in other words they increase their own metabolism. • Valproate inhibits cytochrome P450 enzymes.
  • 52. Pharmacokinetic ConsiderationsPharmacokinetic Considerations • Most AEDs undergo complete or nearly complete absorption when given orally. • Fosphenytoin (prodrug) may be administered intramuscularly if intravenous access cannot be established in cases of frequent repetitive seizures • Diazepam (available as a rectal gel) has been shown to terminate repetitive seizures and can be administered by family members at home. • Phenytoin, fosphenytoin, phenobarbital, diazepam, lorazepam and valproate are available as IV preparations for emergency use. • Most AEDs are metabolized in the liver (P450) by hydroxylation or conjugation. These metabolites are then excreted by the kidney. Gabapentin undergoes no metabolism and is excreted unchanged by the kidney.
  • 53. AED Treatment OptionsAED Treatment Options MyoclonicTonic Primary generalized seizuresPartial seizures Simple Complex Secondary Generalized Ethosuximidephenytoin, carbamazepine, phenobarbital, gabapentin, oxcarbazepine, pregabalin valproic acid, lamotrigine, topiramate, (levetiracetam, zonisamide) Tonic- Clonic Atonic Absence Check notes
  • 54. Status EpilepticusStatus Epilepticus • Treatment – Diazepam, lorazapam IV (fast, short acting) – Followed by phenytoin, fosphenytoin, or phenobarbital (longer acting) when control is established
  • 55. MAIN INDICATIONS OF ANTIEPILEPTIC DRUGS
  • 56. Alternative methods for treatment of epilepsy: • Neurosurgery + laser therapy